Scientists reprogram brain immune cells to fight Alzheimer’s: Study
Researchers in Spain and Switzerland have identified a molecule called OLE that may restore the brain’s natural defenses against Alzheimer’s disease. According to a study published in the journal Cell Death and Disease, OLE reprograms microglia—the brain’s immune cells—to contain toxic beta-amyloid plaques, which improved memory performance in animal models.
How does OLE combat Alzheimer’s disease?
Alzheimer’s disease is characterized by the buildup of beta-amyloid plaques. According to the research, microglia normally remove these deposits but become less effective over time, which can damage brain cells.
The molecule OLE, produced by the PM20D1 gene, restores these immune cells to a protective state. Following treatment, microglia migrated toward plaques and formed a barrier around them, reducing direct contact between the plaques and neurons.
Jose Vicente Sanchez Mut, who leads the Functional Epi-Genomics of Aging and Alzheimer’s Disease laboratory at the IN CSIC-UMH, stated that the process of cell impairment in Alzheimer’s may be reversed. He noted this identifies new therapeutic and research avenues to counteract the disease.
What were the results of the animal and cell tests?
The research team used genetically modified worms (C. elegans) that produce beta-amyloid. Treatment with OLE reduced protein aggregates and improved the animals’ movement, according to the study.
In mouse models, the researchers administered OLE for three months. The treated mice showed fewer beta-amyloid plaques and performed better on memory tests than untreated mice.
Victoria Pozzi, the study’s first author, said single-cell analysis showed microglia were the cells that responded most strongly. This allowed the cells to better contain the damage associated with the disease.
What happens next for OLE development?
The discovery is currently covered by two European patents, including one owned by the Spanish National Research Council (CSIC). Researchers say these patents strengthen the translational potential of the work.
Future efforts may focus on developing therapeutic applications based on these findings. Because OLE improved cell survival in neuronal cultures, it could potentially provide direct protection to neurons in human patients.
Frequently Asked Questions
What is the OLE molecule?
OLE is an experimental molecule produced by the PM20D1 gene that helps restore the protective functions of microglia in the brain.
How did OLE affect the mouse models in the study?
Mice treated with OLE for three months exhibited fewer beta-amyloid plaques and demonstrated improved performance on memory tests.
Which cells in the brain responded most to the treatment?
According to single-cell analysis, microglia were the cells most strongly affected, regaining their ability to move toward and contain toxic plaques.
What role do you believe immune system research will play in the future of memory-loss treatments?